Filter
1231
Filtered Results: 1231
Text search:
Model
Formulary
Featured
Recommendations
117
New Publications
343
Language
Document type
No document type
673
Guidelines
223
Studies & Reports
158
Manuals
80
Strategic & Response Plan
47
Training Material
27
Fact sheets
9
Situation Updates
8
Resource Platforms
5
Brochures
1
Countries / Regions
Latin America and the Carribbean
47
India
40
Kenya
35
South Africa
33
Global
28
Paraguay
26
Ethiopia
25
Nigeria
24
Tanzania
22
Zambia
22
Uganda
21
Nepal
20
Western and Central Europe
19
Indonesia
18
Myanmar / Burma
17
Colombia
16
Liberia
16
Philippines
14
Africa
14
Malawi
11
Venezuela
11
Ukraine
10
Sierra Leone
10
Germany
10
Brazil
10
Namibia
10
Lesotho
9
Rwanda
9
Bangladesh
9
Eastern Europe
9
Ecuador
9
Ghana
8
Syria
8
Botswana
8
Peru
7
South–East Asia Region
7
Bolivia
7
Argentina
7
El Salvador
6
Chile
6
Asia
6
Spain
6
Senegal
5
Burkina Faso
5
Mozambique
5
Haiti
5
Cambodia
5
Cameroon
4
Zimbabwe
4
Turkey
3
Benin
3
Congo, Democratic Republic of
3
Eastern Europe and Central Asia
3
Eswatini/ Swaziland
3
Pakistan
3
Tajikistan
2
Thailand
2
China
2
Jordan
2
West and Central Africa
2
Western Pacific Region
2
Jamaica
2
Southern Africa
2
Vietnam
2
Papua New Guinea
2
Sudan
2
South Sudan
2
Iraq
2
Switzerland
1
Mexico
1
Serbia
1
Albania
1
Singapore
1
Afghanistan
1
Burundi
1
Qatar
1
Guinea
1
USA
1
Dominican Republic
1
Middle East and North Africa
1
Gabon
1
France
1
United Kingdom
1
Portugal
1
Lebanon
1
Egypt
1
Yemen
1
Romania
1
Libya
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
511
Clinical Guidelines
140
Women & Child Health
106
Public Health
66
Key Resources
38
Capacity Building
31
Pharmacy & Technologies
12
Toolboxes
Mental Health
83
AMR
79
TB
73
HIV
71
COVID-19
62
Pharmacy
59
Conflict
31
Rapid Response
30
Disability
30
Caregiver
27
Planetary Health
27
NTDs
18
Refugee
17
NCDs
15
Natural Hazards
9
Ebola
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
7
Global Health Education
7
Social Ethics
5
Cholera
3
Polio
3
Typhoon
1
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
MSF الإرشادات السريرية. دليل التشخيص والعلاج
recommended
Clinical Guidelines. Diagnosis and Treatment Manual.
World Health Organization. (2021). Minimum technical standards and recommendations for reproductive, maternal, newborn and child health care for emergency medical teams. World Health Organization.
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Diabetes mellitus is a major cause of morbidity and mortality in Scotland and worldwide, with an increasing prevalence. In 2009 there were around 228,000 people registered as having diabetes in Scotland, an increase of 3.6% from the preceding year. This increase relates, in part, to the increasing a...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee...
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
